{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:39:14Z","timestamp":1757543954808},"reference-count":26,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991,3]]},"abstract":"<jats:p content-type=\"fine-print\">\u2713 The present study was undertaken to investigate the effect of U-74006F on malondialdehyde (a by-product of lipid peroxidation) in subarachnoid clot. Eighteen cynomolgus monkeys were divided into three groups of six each. There were two U-74006F-treated groups, receiving doses of 0.3 or 1.0 mg\/kg, and a placebo-treated group. Each monkey underwent baseline cerebral angiography followed by right-sided craniectomy and placement of subarachnoid clot around the middle cerebral artery (MCA). Treatment was administered intravenously every 8 hours for 6 days. Seven days after the experimental subarachnoid hemorrhage (SAH), angiography was repeated and the animals were killed. In the placebo-treated group, significant vasospasm occurred in the MCA on the side of the clot (p &lt; 0.01). After U-74006F treatment at both dosages, significantly less vasospasm developed in the clot-side MCA (p &lt; 0.01). The content of malondialdehyde was measured by both the thiobarbituric acid test and high-performance liquid chromatography (HPLC). Comparing the two methods, HPLC proved to be more accurate than the thiobarbituric acid test, especially for measurement of low concentrations of malondialdehyde. In the placebo-treated group, the malondialdehyde content was significantly increased in the Day 7 clot (p &lt; 0.05). In contrast, malondialdehyde content in freshly prepared clot was very low. In the 0.3-mg\/kg U-74006F group, the malondialdehyde content of clot was significantly less at Day 7 compared to clot from the placebo-treated group (p &lt; 0.05). Although the malondialdehyde content of clot from the 1.0 mg\/kg U-74006F-treated group was less than that of placebo, it was not significantly so. Malondialdehyde was not detected in the actual vessel wall of the MCA of any group. These results suggest that lipid peroxidation in subarachnoid clot may play a role in the pathogenesis of vasospasm and that the salutary effects of U-74006F in vasospasm may be mediated by a reduction of lipid peroxidation in SAH.<\/jats:p>","DOI":"10.3171\/jns.1991.74.3.0454","type":"journal-article","created":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T16:16:04Z","timestamp":1242749764000},"page":"454-459","source":"Crossref","is-referenced-by-count":64,"title":["Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot"],"prefix":"10.3171","volume":"74","author":[{"given":"Kenji","family":"Kanamaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce K. A.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teddy","family":"Witbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Grace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Acute Aneurysm Surgery.","first-page":"53","article-title":"Relevance of the metabolism of membrane lipids to cerebral vasospasm and ischemic brain damage","author":"Asano","year":"1987"},{"key":"b2","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"10438","DOI":"10.1016\/S0021-9258(18)60979-2","article-title":"Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation.","volume":"262","author":"Braughler","year":"1987"},{"key":"b3","series-title":"Methods Enzymol","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","article-title":"Microsomal lipid peroxidation.","volume":"52","author":"Buege","year":"1978"},{"key":"b4","series-title":"Ann Biochem","first-page":"284","article-title":"Determination of malondialdehyde by iron-pairing high-performance liquid chromatography.","volume":"146","author":"Bull","year":"1985"},{"key":"b5","series-title":"Lipids","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF02536418","article-title":"The metabolism of malondialdehyde.","volume":"21","author":"Draper","year":"1986"},{"key":"b6","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/01.STR.21.2.328","article-title":"Arachidonic acid metabolism and pathophysiologic aspects of subarachnoid hemorrhage in rats.","volume":"21","author":"Gaetani","year":"1990"},{"key":"b7","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3171\/jns.1988.68.3.0456","article-title":"Effects of the 21-aminosteroid U-74006F on experimental head injury in mice.","volume":"68","author":"Hall","year":"1988"},{"key":"b8","series-title":"Trends Neurosci","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0166-2236(85)90010-4","article-title":"Oxygen radicals and nervous system.","volume":"8","author":"Halliwell","year":"1985"},{"key":"b9","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1227\/00006123-199007000-00004","article-title":"A dosage study of the effect of the 21-aminosteroid U-74006F on chronic cerebral vasospasm in a primate model.","volume":"27","author":"Kanamaru","year":"1990"},{"key":"b10","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3171\/jns.1989.71.6.0909","article-title":"Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage.","volume":"71","author":"Kanamaru","year":"1989"},{"key":"b11","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3171\/jns.1988.69.4.0488","article-title":"CSF leukotriene C4 following subarachnoid hemorrhage.","volume":"69","author":"Paoletti","year":"1988"},{"key":"b12","series-title":"J Clin Invest","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1172\/JCI113759","article-title":"Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate.","volume":"82","author":"Sadrzadeh","year":"1988"},{"key":"b13","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/01.STR.17.2.196","article-title":"Biological defense mechanism in the pathogenesis of prolonged vasospasm in the patients with ruptured intracranial aneurysms.","volume":"17","author":"Sakaki","year":"1986"},{"key":"b14","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.1988.1","article-title":"Free radical reaction and biological defense mechanism in the pathogenesis of prolonged vasospasm in experimental subarachnoid hemorrhage.","volume":"8","author":"Sakaki","year":"1988"},{"key":"b15","series-title":"Neurol Res","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/01616412.1980.11739582","article-title":"Lipid peroxidation as a cause of cerebral vasospasm.","volume":"2","author":"Sano","year":"1980"},{"key":"b16","series-title":"J Appl Biochem","first-page":"70","article-title":"Difference in susceptibility to injury by linoleic acid hydroperoxide between endothelial and smooth muscle cells of arteries.","volume":"7","author":"Sasaguri","year":"1985"},{"key":"b17","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3171\/jns.1981.54.3.0357","article-title":"The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm.","volume":"54","author":"Sasaki","year":"1981"},{"key":"b18","series-title":".Neurosurgery","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1227\/00006123-198809000-00005","article-title":"Influence of blood volume on cerebrospinal fluid levels of arachidonic acid metabolites after subarachnoid hemorrhage: experimental study on the pathogenesis of cerebral vasospasm.","volume":"23","author":"Seifert","year":"1988"},{"key":"b19","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1227\/00006123-198902000-00005","article-title":"A trial of the 21-aminosteroid U-74006F in a primate model of chronic cerebral vasospasm.","volume":"24","author":"Steinke","year":"1989"},{"key":"b20","series-title":"Exp Pathol","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0232-1513(86)80039-1","article-title":"Ultrastructural study of malondialdehyde-induced arterial lesions in chickens.","volume":"29","author":"Toda","year":"1986"},{"key":"b21","series-title":"Neurol Surg","first-page":"1049","article-title":"[Cerebral vasospasm and lipoperoxide damage. Morphological localization and measurement of lipoperoxide in prolonged cerebral vasospasm.]","volume":"12","author":"Tokoro","year":"1984"},{"key":"b22","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0090-3019(89)90115-8","article-title":"Effect of the nonglucocorticoid 21-aminosteroid U74006F on experimental cerebral vasospasm.","volume":"31","author":"Vollmer","year":"1989"},{"key":"b23","series-title":"Neurol Med Chir","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2176\/nmc.28.645","article-title":"[Changes in glutathione peroxidase and lipid peroxides in cerebrospinal fluid and serum after subarachnoid hemorrhage.]","volume":"28","author":"Watanabe","year":"1988"},{"key":"b24","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1161\/01.STR.20.4.527","article-title":"Biosynthesis of leukotrienes in canine cerebral vasospasm.","volume":"20","author":"Yokota","year":"1989"},{"key":"b25","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.STR.18.2.512","article-title":"Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm.","volume":"18","author":"Yokota","year":"1987"},{"key":"b26","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3171\/jns.1989.71.1.0098","article-title":"Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage.","volume":"71","author":"Zuccarello","year":"1989"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/74\/3\/article-p454.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/74\/3\/article-p454.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/74\/3\/article-p454.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:26:15Z","timestamp":1679862375000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/74\/3\/article-p454.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,3]]},"references-count":26,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/jns.1991.74.3.0454","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[1991,3]]}}}